SG165339A1 - Incorporation of non-naturally encoded amino acids into proteins - Google Patents

Incorporation of non-naturally encoded amino acids into proteins

Info

Publication number
SG165339A1
SG165339A1 SG201006401-2A SG2010064012A SG165339A1 SG 165339 A1 SG165339 A1 SG 165339A1 SG 2010064012 A SG2010064012 A SG 2010064012A SG 165339 A1 SG165339 A1 SG 165339A1
Authority
SG
Singapore
Prior art keywords
amino acids
encoded amino
naturally encoded
incorporation
proteins
Prior art date
Application number
SG201006401-2A
Other languages
English (en)
Inventor
Ho Sung Cho
Original Assignee
Ambrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrx Inc filed Critical Ambrx Inc
Publication of SG165339A1 publication Critical patent/SG165339A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SG201006401-2A 2005-06-03 2006-06-02 Incorporation of non-naturally encoded amino acids into proteins SG165339A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68760305P 2005-06-03 2005-06-03

Publications (1)

Publication Number Publication Date
SG165339A1 true SG165339A1 (en) 2010-10-28

Family

ID=37498945

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201006401-2A SG165339A1 (en) 2005-06-03 2006-06-02 Incorporation of non-naturally encoded amino acids into proteins

Country Status (11)

Country Link
US (1) US20080227205A1 (es)
EP (1) EP1891092A4 (es)
JP (1) JP2008541766A (es)
KR (1) KR20080026120A (es)
CN (1) CN101238143A (es)
AU (1) AU2006255280A1 (es)
CA (1) CA2608192A1 (es)
IL (1) IL187191A0 (es)
MX (1) MX2007015106A (es)
SG (1) SG165339A1 (es)
WO (1) WO2006132969A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287639A1 (en) 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
US20090240029A1 (en) * 2005-12-30 2009-09-24 Ambrx, Inc. Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
WO2007103307A2 (en) 2006-03-03 2007-09-13 California Institute Of Technology Site-specific incorporation of amino acids into molecules
CN104163864B (zh) * 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
JP5547083B2 (ja) 2007-11-20 2014-07-09 アンブルックス,インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
WO2009075788A1 (en) * 2007-12-05 2009-06-18 Semprus Biociences Corporation Synthetic non-fouling amino acids
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
JP5751641B2 (ja) 2009-05-06 2015-07-22 ヤンセン バイオテツク,インコーポレーテツド メラノコルチン受容体結合コンジュゲート
WO2011079293A1 (en) * 2009-12-23 2011-06-30 Ambrx, Inc Tumor necrosis factor-related apoptosis inducing ligand polypeptides and their uses
CN103044539B (zh) * 2010-04-09 2014-10-22 苏州元基生物技术有限公司 重组促红细胞生成素及制备方法
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
MX346786B (es) 2010-08-17 2017-03-31 Ambrx Inc Polipeptidos de relaxina modificados y sus usos.
JP6162606B2 (ja) 2011-01-14 2017-07-12 レッドウッド バイオサイエンス, インコーポレイテッド アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法
EP2804631B1 (en) 2012-01-20 2021-03-17 i2 Pharmaceuticals, Inc. Surrobody conjugates
CN105420203B (zh) * 2014-09-03 2018-11-16 中国科学院生物物理研究所 酪氨酸类似物翻译系统和基因编码的蛋白质光致电子转移荧光传感器蛋白家族
PL3412302T3 (pl) * 2014-10-24 2021-11-02 Bristol-Myers Squibb Company Zmodyfikowane polipeptydy fgf-21 i ich zastosowania
WO2017189432A1 (en) 2016-04-26 2017-11-02 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
JP7527537B2 (ja) * 2016-05-10 2024-08-05 ソニーグループ株式会社 ペプチド骨格を有する超明色ポリマー染料
CN110637027B (zh) 2017-02-08 2024-08-30 百时美施贵宝公司 包含药代动力学增强子的修饰的松弛素多肽及其用途
EP3381932A1 (en) 2017-03-28 2018-10-03 Technische Universität Berlin Modified mussel proteins, uses thereof and related compounds
CN112375774A (zh) * 2020-10-26 2021-02-19 浙江新码生物医药有限公司 一种重组蛋白表达用工程菌株的构建方法
CN112279906B (zh) * 2020-10-30 2022-09-20 浙江新码生物医药有限公司 人白细胞介素2-聚乙二醇偶联物及其制备方法与应用
AU2023218678A1 (en) 2022-02-09 2024-08-01 Daiichi Sankyo Company, Limited Environmentally responsive masked antibody and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586207B2 (en) * 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
AU2002303431C1 (en) * 2001-04-19 2008-03-06 The Regents Of The University Of California Methods and composition for the production of orthoganal tRNA-aminoacyltRNA synthetase pairs
US8906676B2 (en) * 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
CA2590429C (en) * 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof

Also Published As

Publication number Publication date
MX2007015106A (es) 2008-02-15
WO2006132969A3 (en) 2007-11-22
CN101238143A (zh) 2008-08-06
EP1891092A4 (en) 2011-12-21
US20080227205A1 (en) 2008-09-18
JP2008541766A (ja) 2008-11-27
CA2608192A1 (en) 2006-12-14
EP1891092A2 (en) 2008-02-27
WO2006132969A2 (en) 2006-12-14
KR20080026120A (ko) 2008-03-24
AU2006255280A1 (en) 2006-12-14
IL187191A0 (en) 2008-02-09

Similar Documents

Publication Publication Date Title
SG165339A1 (en) Incorporation of non-naturally encoded amino acids into proteins
WO2006017538A3 (en) Hk1-binding proteins
IL187188A0 (en) Improved human interferon molecules and their uses
WO2010011944A3 (en) Protein screeing methods
HK1205193A1 (en) Recombinant n-glycosylated proteins from procaryotic cells n-
GB2431658A (en) Biosynthetic polypeptides utilizing non-naturally encoded amino acids
WO2002085923A3 (en) In vivo incorporation of unnatural amino acids
IL209386A0 (en) Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
IL196893A0 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
WO2008066583A3 (en) Cell-free synthesis of proteins containing unnatural amino acids
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
WO2006111524A3 (en) Il-21 variants
PT1991680E (pt) Sistema para a expressão de componentes ortogonais de tradução em células hospedeiras eubacterianas
WO2006116716A3 (en) Materials and methods for enhanced degradation of mutant proteins associated with human disease
WO2006113681A3 (en) Plant-derived elastin binding protein ligands and methods of using the same
WO2007075438A3 (en) Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
WO2006073976A3 (en) Compositions, methods, and kits for enhancing protein expression, solubility and isolation
MX2011007107A (es) Composiciones de hidrolizado de proteina.
DE602006017882D1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
WO2007081419A3 (en) Compositions and methods related to anti-fgf agents
WO2008131002A3 (en) Generation of acyl amino acids
WO2007100874A3 (en) Compositions containing peptides with non-natural amino acids and methods of use
WO2008094316A3 (en) Novel branchiostoma derived fluorescent proteins
WO2010041145A3 (en) Il-17-mediated transfection methods
EP1885867A4 (en) NEW PROCEDURES